SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009987
Filing Date
2016-11-14
Accepted
2016-11-14 07:01:45
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-20160930x10q.htm 10-Q 1751070
2 EX-31.1 syrs-20160930ex31106d849.htm EX-31.1 10085
3 EX-31.2 syrs-20160930ex312d8c537.htm EX-31.2 10639
4 EX-32.1 syrs-20160930ex321535ad7.htm EX-32.1 7295
5 EX-32.2 syrs-20160930ex322465615.htm EX-32.2 7310
  Complete submission text file 0001558370-16-009987.txt   4541948

Data Files

Seq Description Document Type Size
6 EX-101.INS syrs-20160930.xml EX-101.INS 639071
7 EX-101.SCH syrs-20160930.xsd EX-101.SCH 31270
8 EX-101.CAL syrs-20160930_cal.xml EX-101.CAL 29660
9 EX-101.DEF syrs-20160930_def.xml EX-101.DEF 138275
10 EX-101.LAB syrs-20160930_lab.xml EX-101.LAB 331003
11 EX-101.PRE syrs-20160930_pre.xml EX-101.PRE 235077
Mailing Address 480 ARSENAL STREET SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 130 WATERTOWN MA 02472 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 161990388
SIC: 2834 Pharmaceutical Preparations